Validation of the French version of the Vulnerable Elders Survey-13 (VES-13)
Background Identifying and assessing degree and type of frailty among older persons is a major challenge when targeting high risk populations to identify preventive interventions. The Vulnerable Elders Survey-(VES-13) is a simple instrument to identify frailty defined as risk for death, functional d...
Uložené v:
| Vydané v: | BMC medical research methodology Ročník 20; číslo 1; s. 21 - 6 |
|---|---|
| Hlavní autori: | , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
London
BioMed Central
05.02.2020
BioMed Central Ltd Springer Nature B.V BMC |
| Predmet: | |
| ISSN: | 1471-2288, 1471-2288 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Background
Identifying and assessing degree and type of frailty among older persons is a major challenge when targeting high risk populations to identify preventive interventions. The Vulnerable Elders Survey-(VES-13) is a simple instrument to identify frailty defined as risk for death, functional decline or institutionalization.
Objective
Translate VES-13 into French and validate it.
Methods
The French version of VES-13 was developed by forward-backward translation of the VES-13 survey instrument. The authors assessed its feasibility, construct validity, and ability to predict the combined outcomes of admission to institution or death at 18 months, in 135 persons over 70 years of age living in the community. Subjects were recruited from three settings: Group 1 – a health prevention center (
n
= 45); Group 2 – an ambulatory care geriatric clinic (
n
= 40); and Group 3 – an intermediate care hospital unit (
n
= 50). The combined outcomes data were recorded by telephone interview with participants or a proxy.
Results
Feasibility of the French version, named Echelle de Vulnérabilité des Ainés-13 or EVA-13, was excellent. The scale classified 5 (11%) persons as vulnerable (score of 3 or more) in Group 1, 23 (58%) in Group 2 and 45 (90%) in Group 3 (
p
< 0.001) with scores of 0.91 +/− 1.16, 4.27 +/− 3.17 and 6.90 +/− 3.17, respectively (
p
< 0.001). At follow-up, among the 60 non-vulnerable subjects, 58 (96%) were alive and living at home, whereas 46 (65%) of the 70 vulnerable subjects were alive and living at home (
p
< 0.001).
Conclusions
EVA-13 was determined to be valid and reliable. |
|---|---|
| AbstractList | Identifying and assessing degree and type of frailty among older persons is a major challenge when targeting high risk populations to identify preventive interventions. The Vulnerable Elders Survey-(VES-13) is a simple instrument to identify frailty defined as risk for death, functional decline or institutionalization. Translate VES-13 into French and validate it. The French version of VES-13 was developed by forward-backward translation of the VES-13 survey instrument. The authors assessed its feasibility, construct validity, and ability to predict the combined outcomes of admission to institution or death at 18 months, in 135 persons over 70 years of age living in the community. Subjects were recruited from three settings: Group 1 - a health prevention center (n = 45); Group 2 - an ambulatory care geriatric clinic (n = 40); and Group 3 - an intermediate care hospital unit (n = 50). The combined outcomes data were recorded by telephone interview with participants or a proxy. Feasibility of the French version, named Echelle de Vulnérabilité des Ainés-13 or EVA-13, was excellent. The scale classified 5 (11%) persons as vulnerable (score of 3 or more) in Group 1, 23 (58%) in Group 2 and 45 (90%) in Group 3 (p < 0.001) with scores of 0.91 +/- 1.16, 4.27 +/- 3.17 and 6.90 +/- 3.17, respectively (p < 0.001). At follow-up, among the 60 non-vulnerable subjects, 58 (96%) were alive and living at home, whereas 46 (65%) of the 70 vulnerable subjects were alive and living at home (p < 0.001). EVA-13 was determined to be valid and reliable. Abstract Background Identifying and assessing degree and type of frailty among older persons is a major challenge when targeting high risk populations to identify preventive interventions. The Vulnerable Elders Survey-(VES-13) is a simple instrument to identify frailty defined as risk for death, functional decline or institutionalization. Objective Translate VES-13 into French and validate it. Methods The French version of VES-13 was developed by forward-backward translation of the VES-13 survey instrument. The authors assessed its feasibility, construct validity, and ability to predict the combined outcomes of admission to institution or death at 18 months, in 135 persons over 70 years of age living in the community. Subjects were recruited from three settings: Group 1 – a health prevention center (n = 45); Group 2 – an ambulatory care geriatric clinic (n = 40); and Group 3 – an intermediate care hospital unit (n = 50). The combined outcomes data were recorded by telephone interview with participants or a proxy. Results Feasibility of the French version, named Echelle de Vulnérabilité des Ainés-13 or EVA-13, was excellent. The scale classified 5 (11%) persons as vulnerable (score of 3 or more) in Group 1, 23 (58%) in Group 2 and 45 (90%) in Group 3 (p < 0.001) with scores of 0.91 +/− 1.16, 4.27 +/− 3.17 and 6.90 +/− 3.17, respectively (p < 0.001). At follow-up, among the 60 non-vulnerable subjects, 58 (96%) were alive and living at home, whereas 46 (65%) of the 70 vulnerable subjects were alive and living at home (p < 0.001). Conclusions EVA-13 was determined to be valid and reliable. Abstract Background Identifying and assessing degree and type of frailty among older persons is a major challenge when targeting high risk populations to identify preventive interventions. The Vulnerable Elders Survey-(VES-13) is a simple instrument to identify frailty defined as risk for death, functional decline or institutionalization. Objective Translate VES-13 into French and validate it. Methods The French version of VES-13 was developed by forward-backward translation of the VES-13 survey instrument. The authors assessed its feasibility, construct validity, and ability to predict the combined outcomes of admission to institution or death at 18 months, in 135 persons over 70 years of age living in the community. Subjects were recruited from three settings: Group 1 – a health prevention center ( n = 45); Group 2 – an ambulatory care geriatric clinic ( n = 40); and Group 3 – an intermediate care hospital unit ( n = 50). The combined outcomes data were recorded by telephone interview with participants or a proxy. Results Feasibility of the French version, named Echelle de Vulnérabilité des Ainés-13 or EVA-13, was excellent. The scale classified 5 (11%) persons as vulnerable (score of 3 or more) in Group 1, 23 (58%) in Group 2 and 45 (90%) in Group 3 ( p < 0.001) with scores of 0.91 +/− 1.16, 4.27 +/− 3.17 and 6.90 +/− 3.17, respectively ( p < 0.001). At follow-up, among the 60 non-vulnerable subjects, 58 (96%) were alive and living at home, whereas 46 (65%) of the 70 vulnerable subjects were alive and living at home ( p < 0.001). Conclusions EVA-13 was determined to be valid and reliable. Background Identifying and assessing degree and type of frailty among older persons is a major challenge when targeting high risk populations to identify preventive interventions. The Vulnerable Elders Survey-(VES-13) is a simple instrument to identify frailty defined as risk for death, functional decline or institutionalization. Objective Translate VES-13 into French and validate it. Methods The French version of VES-13 was developed by forward-backward translation of the VES-13 survey instrument. The authors assessed its feasibility, construct validity, and ability to predict the combined outcomes of admission to institution or death at 18 months, in 135 persons over 70 years of age living in the community. Subjects were recruited from three settings: Group 1 – a health prevention center ( n = 45); Group 2 – an ambulatory care geriatric clinic ( n = 40); and Group 3 – an intermediate care hospital unit ( n = 50). The combined outcomes data were recorded by telephone interview with participants or a proxy. Results Feasibility of the French version, named Echelle de Vulnérabilité des Ainés-13 or EVA-13, was excellent. The scale classified 5 (11%) persons as vulnerable (score of 3 or more) in Group 1, 23 (58%) in Group 2 and 45 (90%) in Group 3 ( p < 0.001) with scores of 0.91 +/− 1.16, 4.27 +/− 3.17 and 6.90 +/− 3.17, respectively ( p < 0.001). At follow-up, among the 60 non-vulnerable subjects, 58 (96%) were alive and living at home, whereas 46 (65%) of the 70 vulnerable subjects were alive and living at home ( p < 0.001). Conclusions EVA-13 was determined to be valid and reliable. Identifying and assessing degree and type of frailty among older persons is a major challenge when targeting high risk populations to identify preventive interventions. The Vulnerable Elders Survey-(VES-13) is a simple instrument to identify frailty defined as risk for death, functional decline or institutionalization. Translate VES-13 into French and validate it. The French version of VES-13 was developed by forward-backward translation of the VES-13 survey instrument. The authors assessed its feasibility, construct validity, and ability to predict the combined outcomes of admission to institution or death at 18 months, in 135 persons over 70 years of age living in the community. Subjects were recruited from three settings: Group 1 - a health prevention center (n = 45); Group 2 - an ambulatory care geriatric clinic (n = 40); and Group 3 - an intermediate care hospital unit (n = 50). The combined outcomes data were recorded by telephone interview with participants or a proxy. Feasibility of the French version, named Echelle de Vulnérabilité des Ainés-13 or EVA-13, was excellent. The scale classified 5 (11%) persons as vulnerable (score of 3 or more) in Group 1, 23 (58%) in Group 2 and 45 (90%) in Group 3 (p < 0.001) with scores of 0.91 +/- 1.16, 4.27 +/- 3.17 and 6.90 +/- 3.17, respectively (p < 0.001). At follow-up, among the 60 non-vulnerable subjects, 58 (96%) were alive and living at home, whereas 46 (65%) of the 70 vulnerable subjects were alive and living at home (p < 0.001). EVA-13 was determined to be valid and reliable. Background Identifying and assessing degree and type of frailty among older persons is a major challenge when targeting high risk populations to identify preventive interventions. The Vulnerable Elders Survey-(VES-13) is a simple instrument to identify frailty defined as risk for death, functional decline or institutionalization. Objective Translate VES-13 into French and validate it. Methods The French version of VES-13 was developed by forward-backward translation of the VES-13 survey instrument. The authors assessed its feasibility, construct validity, and ability to predict the combined outcomes of admission to institution or death at 18 months, in 135 persons over 70 years of age living in the community. Subjects were recruited from three settings: Group 1 - a health prevention center (n = 45); Group 2 - an ambulatory care geriatric clinic (n = 40); and Group 3 - an intermediate care hospital unit (n = 50). The combined outcomes data were recorded by telephone interview with participants or a proxy. Results Feasibility of the French version, named Echelle de Vulnérabilité des Ainés-13 or EVA-13, was excellent. The scale classified 5 (11%) persons as vulnerable (score of 3 or more) in Group 1, 23 (58%) in Group 2 and 45 (90%) in Group 3 (p < 0.001) with scores of 0.91 +/- 1.16, 4.27 +/- 3.17 and 6.90 +/- 3.17, respectively (p < 0.001). At follow-up, among the 60 non-vulnerable subjects, 58 (96%) were alive and living at home, whereas 46 (65%) of the 70 vulnerable subjects were alive and living at home (p < 0.001). Conclusions EVA-13 was determined to be valid and reliable. Keywords: Frailty, Functional decline, Vulnerability, Mortality, Vulnerable elders survey-13, French version, VES-13, EVA-13 Background Identifying and assessing degree and type of frailty among older persons is a major challenge when targeting high risk populations to identify preventive interventions. The Vulnerable Elders Survey-(VES-13) is a simple instrument to identify frailty defined as risk for death, functional decline or institutionalization. Objective Translate VES-13 into French and validate it. Methods The French version of VES-13 was developed by forward-backward translation of the VES-13 survey instrument. The authors assessed its feasibility, construct validity, and ability to predict the combined outcomes of admission to institution or death at 18 months, in 135 persons over 70 years of age living in the community. Subjects were recruited from three settings: Group 1 – a health prevention center (n = 45); Group 2 – an ambulatory care geriatric clinic (n = 40); and Group 3 – an intermediate care hospital unit (n = 50). The combined outcomes data were recorded by telephone interview with participants or a proxy. Results Feasibility of the French version, named Echelle de Vulnérabilité des Ainés-13 or EVA-13, was excellent. The scale classified 5 (11%) persons as vulnerable (score of 3 or more) in Group 1, 23 (58%) in Group 2 and 45 (90%) in Group 3 (p < 0.001) with scores of 0.91 +/− 1.16, 4.27 +/− 3.17 and 6.90 +/− 3.17, respectively (p < 0.001). At follow-up, among the 60 non-vulnerable subjects, 58 (96%) were alive and living at home, whereas 46 (65%) of the 70 vulnerable subjects were alive and living at home (p < 0.001). Conclusions EVA-13 was determined to be valid and reliable. Identifying and assessing degree and type of frailty among older persons is a major challenge when targeting high risk populations to identify preventive interventions. The Vulnerable Elders Survey-(VES-13) is a simple instrument to identify frailty defined as risk for death, functional decline or institutionalization.BACKGROUNDIdentifying and assessing degree and type of frailty among older persons is a major challenge when targeting high risk populations to identify preventive interventions. The Vulnerable Elders Survey-(VES-13) is a simple instrument to identify frailty defined as risk for death, functional decline or institutionalization.Translate VES-13 into French and validate it.OBJECTIVETranslate VES-13 into French and validate it.The French version of VES-13 was developed by forward-backward translation of the VES-13 survey instrument. The authors assessed its feasibility, construct validity, and ability to predict the combined outcomes of admission to institution or death at 18 months, in 135 persons over 70 years of age living in the community. Subjects were recruited from three settings: Group 1 - a health prevention center (n = 45); Group 2 - an ambulatory care geriatric clinic (n = 40); and Group 3 - an intermediate care hospital unit (n = 50). The combined outcomes data were recorded by telephone interview with participants or a proxy.METHODSThe French version of VES-13 was developed by forward-backward translation of the VES-13 survey instrument. The authors assessed its feasibility, construct validity, and ability to predict the combined outcomes of admission to institution or death at 18 months, in 135 persons over 70 years of age living in the community. Subjects were recruited from three settings: Group 1 - a health prevention center (n = 45); Group 2 - an ambulatory care geriatric clinic (n = 40); and Group 3 - an intermediate care hospital unit (n = 50). The combined outcomes data were recorded by telephone interview with participants or a proxy.Feasibility of the French version, named Echelle de Vulnérabilité des Ainés-13 or EVA-13, was excellent. The scale classified 5 (11%) persons as vulnerable (score of 3 or more) in Group 1, 23 (58%) in Group 2 and 45 (90%) in Group 3 (p < 0.001) with scores of 0.91 +/- 1.16, 4.27 +/- 3.17 and 6.90 +/- 3.17, respectively (p < 0.001). At follow-up, among the 60 non-vulnerable subjects, 58 (96%) were alive and living at home, whereas 46 (65%) of the 70 vulnerable subjects were alive and living at home (p < 0.001).RESULTSFeasibility of the French version, named Echelle de Vulnérabilité des Ainés-13 or EVA-13, was excellent. The scale classified 5 (11%) persons as vulnerable (score of 3 or more) in Group 1, 23 (58%) in Group 2 and 45 (90%) in Group 3 (p < 0.001) with scores of 0.91 +/- 1.16, 4.27 +/- 3.17 and 6.90 +/- 3.17, respectively (p < 0.001). At follow-up, among the 60 non-vulnerable subjects, 58 (96%) were alive and living at home, whereas 46 (65%) of the 70 vulnerable subjects were alive and living at home (p < 0.001).EVA-13 was determined to be valid and reliable.CONCLUSIONSEVA-13 was determined to be valid and reliable. |
| ArticleNumber | 21 |
| Audience | Academic |
| Author | Pariel, Sylvie Zeisel, John Khellaf, Lyamna Belmin, Joël Valembois, Lucie Jarzebowski, Witold Lafuente-Lafuente, Carmelo |
| Author_xml | – sequence: 1 givenname: Joël orcidid: 0000-0003-1630-9582 surname: Belmin fullname: Belmin, Joël email: j.belmin@aphp.fr organization: Service de gériatrie à orientation cardiovasculaire et neuropsychogériatrique, Hôpital Charles Foix, Assistance Publique-Hôpitaux de Paris, Faculté de Médecine, Sorbonne Université, Service de Gériatrie, Hôpital Charles Foix et Université Pierre et Marie Curie – sequence: 2 givenname: Lyamna surname: Khellaf fullname: Khellaf, Lyamna organization: Service de gériatrie à orientation cardiovasculaire et neuropsychogériatrique, Hôpital Charles Foix, Assistance Publique-Hôpitaux de Paris – sequence: 3 givenname: Sylvie surname: Pariel fullname: Pariel, Sylvie organization: Service de Gériatrie Ambulatoire, Hôpital Charles Foix, Assistance Publique-Hôpitaux de Paris – sequence: 4 givenname: Witold surname: Jarzebowski fullname: Jarzebowski, Witold organization: Service de gériatrie à orientation cardiovasculaire et neuropsychogériatrique, Hôpital Charles Foix, Assistance Publique-Hôpitaux de Paris, Service de Gériatrie Centre Hospitalier Général – sequence: 5 givenname: Lucie surname: Valembois fullname: Valembois, Lucie organization: Service de gériatrie à orientation cardiovasculaire et neuropsychogériatrique, Hôpital Charles Foix, Assistance Publique-Hôpitaux de Paris, Faculté de Médecine, Sorbonne Université – sequence: 6 givenname: John surname: Zeisel fullname: Zeisel, John organization: Hearthstone Alzheimer Care – sequence: 7 givenname: Carmelo surname: Lafuente-Lafuente fullname: Lafuente-Lafuente, Carmelo organization: Service de gériatrie à orientation cardiovasculaire et neuropsychogériatrique, Hôpital Charles Foix, Assistance Publique-Hôpitaux de Paris, Faculté de Médecine, Sorbonne Université |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32024470$$D View this record in MEDLINE/PubMed https://hal.u-pec.fr/hal-04146220$$DView record in HAL |
| BookMark | eNp9kl1r2zAYhc3oWD-2H7CbYdhNe-Hu1Ycl-WYQSroWArvollshyVKi4FidbIf230-p2zUJ2_CFzKtzHkmHc5odtaG1WfYRwSVCgn3pEBacFoChgApB8fAmO0GUowJjIY52_o-z065bASAuCHuXHRMMmFIOJ9lsrhpfq96HNg8u75c2v462Nct8Y2O3M50PTWuj0o3Np02d9vK7IW7sY4FIfj6f3qX14n321qmmsx-e17Ps5_X0x9VNMfv-7fZqMisMI7wvbMmNE8wQVru6FhQLbZlwQJzWplLGadBQOqIdKsFwVZdGY1YLzHQFtOLkLLsduXVQK3kf_VrFRxmUl0-DEBdSxd6bxkpSpjOrkpXIaio0Fgio5RSlaIixtU6sryPrftBrWxvb9lE1e9D9ndYv5SJsJAcgBFUJcDEClge2m8lMbmdAEWUYwwYl7fnzYTH8GmzXy7XvjG0a1dowdBKTEkOJacWS9POBdBWG2KZYtyqeQoOyfFUtVHqsb11IdzRbqJwwxCiGSmxZl39Rpa-2a29Sp5xP8z3Dp91Q_jzrpTdJwEeBiaHronXS-P6pRYnsG4lAbhsqx4bK1FC5bah8SE504HyB_8-DR0-XtO3Cxtcs_m36DfR487Q |
| CitedBy_id | crossref_primary_10_1007_s12603_020_1498_x crossref_primary_10_1007_s12603_020_1492_3 crossref_primary_10_1016_j_jgo_2022_04_014 crossref_primary_10_1111_jgs_17451 crossref_primary_10_1016_j_revmed_2021_10_006 crossref_primary_10_2196_42017 |
| Cites_doi | 10.1016/j.amjmed.2005.01.062 10.1186/s12877-017-0460-1 10.1097/TA.0000000000000929 10.1080/09638288.2016.1212282 10.1111/j.1532-5415.2009.02497.x 10.1093/gerona/56.3.M146 10.1046/j.1532-5415.2001.49281.x 10.1503/cmaj.171509 10.1097/MD.0000000000012298 10.1016/j.arr.2010.09.001 10.1111/j.1532-5415.2011.03861.x 10.1503/cmaj.050051 10.1519/JPT.0000000000000097 10.1111/j.1532-5415.2006.00745.x 10.1111/j.1532-5415.2009.02137.x 10.1016/S0140-6736(12)62167-9 10.1016/j.archger.2017.09.005 10.1016/j.jamda.2013.03.022 10.1016/j.cger.2017.09.004 10.1111/j.1532-5415.2008.01656.x 10.1093/annonc/mdu210 10.1111/j.1532-5415.2008.01921.x 10.1002/cncr.30046 10.1111/j.1532-5415.2011.03493.x |
| ContentType | Journal Article |
| Copyright | The Author(s). 2020 COPYRIGHT 2020 BioMed Central Ltd. 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. licence_http://creativecommons.org/publicdomain/zero |
| Copyright_xml | – notice: The Author(s). 2020 – notice: COPYRIGHT 2020 BioMed Central Ltd. – notice: 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: licence_http://creativecommons.org/publicdomain/zero |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 1XC VOOES 5PM DOA |
| DOI | 10.1186/s12874-020-0910-x |
| DatabaseName | SpringerOpen CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic Hyper Article en Ligne (HAL) Hyper Article en Ligne (HAL) (Open Access) PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE Publicly Available Content Database MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ (Directory of Open Access Journals) url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1471-2288 |
| EndPage | 6 |
| ExternalDocumentID | oai_doaj_org_article_35c6395651eb48b28104e7411473cedb PMC7003319 oai:HAL:hal-04146220v1 A616420986 32024470 10_1186_s12874_020_0910_x |
| Genre | Validation Study Journal Article |
| GeographicLocations | France |
| GeographicLocations_xml | – name: France |
| GroupedDBID | --- 0R~ 23N 2WC 53G 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABDBF ABUWG ACGFO ACGFS ACIHN ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M48 MK0 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP W2D WOQ WOW XSB AAYXX AFFHD CITATION ALIPV CGR CUY CVF ECM EIF NPM 3V. 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQUKI PRINS 7X8 1XC 2VQ 4.4 ADCSY AGGLG AHSBF C1A EJD H13 IPNFZ RIG VOOES 5PM |
| ID | FETCH-LOGICAL-c637t-e57cf86c36dfdd8428be68f03fbbc9acfb0b05f3bf150c7ad5cb26d826b904973 |
| IEDL.DBID | RSV |
| ISICitedReferencesCount | 9 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000513699400001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1471-2288 |
| IngestDate | Fri Oct 03 12:25:59 EDT 2025 Tue Nov 04 01:43:59 EST 2025 Wed Dec 10 12:40:45 EST 2025 Wed Oct 01 14:12:01 EDT 2025 Tue Oct 07 05:22:06 EDT 2025 Tue Nov 11 10:44:17 EST 2025 Tue Nov 04 18:07:37 EST 2025 Thu Apr 03 07:04:34 EDT 2025 Sat Nov 29 06:38:58 EST 2025 Tue Nov 18 22:20:05 EST 2025 Sat Sep 06 07:35:34 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Vulnerable elders survey-13 Functional decline French version Mortality EVA-13 VES-13 Frailty Vulnerability |
| Language | English |
| License | licence_http://creativecommons.org/publicdomain/zero/: http://creativecommons.org/publicdomain/zero Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c637t-e57cf86c36dfdd8428be68f03fbbc9acfb0b05f3bf150c7ad5cb26d826b904973 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Undefined-3 |
| ORCID | 0000-0003-1630-9582 |
| OpenAccessLink | https://link.springer.com/10.1186/s12874-020-0910-x |
| PMID | 32024470 |
| PQID | 2357428055 |
| PQPubID | 42579 |
| PageCount | 6 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_35c6395651eb48b28104e7411473cedb pubmedcentral_primary_oai_pubmedcentral_nih_gov_7003319 hal_primary_oai_HAL_hal_04146220v1 proquest_miscellaneous_2352052496 proquest_journals_2357428055 gale_infotracmisc_A616420986 gale_infotracacademiconefile_A616420986 pubmed_primary_32024470 crossref_citationtrail_10_1186_s12874_020_0910_x crossref_primary_10_1186_s12874_020_0910_x springer_journals_10_1186_s12874_020_0910_x |
| PublicationCentury | 2000 |
| PublicationDate | 2020-02-05 |
| PublicationDateYYYYMMDD | 2020-02-05 |
| PublicationDate_xml | – month: 02 year: 2020 text: 2020-02-05 day: 05 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | BMC medical research methodology |
| PublicationTitleAbbrev | BMC Med Res Methodol |
| PublicationTitleAlternate | BMC Med Res Methodol |
| PublicationYear | 2020 |
| Publisher | BioMed Central BioMed Central Ltd Springer Nature B.V BMC |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: Springer Nature B.V – name: BMC |
| References | G Kojima (910_CR10) 2017; 39 J Walston (910_CR13) 2006; 54 AM Kulminski (910_CR4) 2008; 56 M Abbasi (910_CR15) 2018; 190 CA Maxwell (910_CR20) 2016; 80 M Tomczak (910_CR23) 2014 L Min (910_CR19) 2011; 59 CM Boyd (910_CR1) 2005; 118 A Ferrero (910_CR22) 2018; 97 LP Fried (910_CR6) 2001; 56 A Clegg (910_CR9) 2013; 381 D Saliba (910_CR18) 2001; 49 L Decoster (910_CR12) 2015; 26 LC Min (910_CR16) 2008; 56 J Wang (910_CR24) 2018; 74 L Min (910_CR17) 2009; 57 J Walston (910_CR2) 2018; 34 C Owusu (910_CR21) 2016; 122 E Wallace (910_CR25) 2017; 17 K Rockwood (910_CR14) 2005; 173 S Gustafsson (910_CR11) 2012; 60 JE Morley (910_CR3) 2013; 14 G Kojima (910_CR8) 2018; 41 KE Ensrud (910_CR7) 2009; 57 NM de Vries (910_CR5) 2011; 10 |
| References_xml | – volume: 118 start-page: 1225 issue: 11 year: 2005 ident: 910_CR1 publication-title: Am J Med doi: 10.1016/j.amjmed.2005.01.062 – volume: 17 start-page: 69 issue: 1 year: 2017 ident: 910_CR25 publication-title: BMC Geriatr doi: 10.1186/s12877-017-0460-1 – start-page: 7 volume-title: The need to report effect size estimates revisited. An overview of some recommended measures of effect size year: 2014 ident: 910_CR23 – volume: 80 start-page: 195 issue: 2 year: 2016 ident: 910_CR20 publication-title: J Trauma Acute Care Surg doi: 10.1097/TA.0000000000000929 – volume: 39 start-page: 1897 issue: 19 year: 2017 ident: 910_CR10 publication-title: Disabil Rehabil doi: 10.1080/09638288.2016.1212282 – volume: 57 start-page: 2070 issue: 11 year: 2009 ident: 910_CR17 publication-title: J Am Geriatr Soc doi: 10.1111/j.1532-5415.2009.02497.x – volume: 56 start-page: M146 issue: 3 year: 2001 ident: 910_CR6 publication-title: J Gerontol A Biol Sci Med Sci doi: 10.1093/gerona/56.3.M146 – volume: 49 start-page: 1691 issue: 12 year: 2001 ident: 910_CR18 publication-title: J Am Geriatr Soc doi: 10.1046/j.1532-5415.2001.49281.x – volume: 190 start-page: E1134 issue: 38 year: 2018 ident: 910_CR15 publication-title: CMAJ doi: 10.1503/cmaj.171509 – volume: 97 start-page: e12298 issue: 39 year: 2018 ident: 910_CR22 publication-title: Medicine (Baltimore) doi: 10.1097/MD.0000000000012298 – volume: 10 start-page: 104 issue: 1 year: 2011 ident: 910_CR5 publication-title: Ageing Res Rev doi: 10.1016/j.arr.2010.09.001 – volume: 60 start-page: 447 issue: 3 year: 2012 ident: 910_CR11 publication-title: J Am Geriatr Soc doi: 10.1111/j.1532-5415.2011.03861.x – volume: 173 start-page: 489 issue: 5 year: 2005 ident: 910_CR14 publication-title: CMAJ doi: 10.1503/cmaj.050051 – volume: 41 start-page: 42 issue: 1 year: 2018 ident: 910_CR8 publication-title: J Geriatr Phys Ther 2001 doi: 10.1519/JPT.0000000000000097 – volume: 54 start-page: 991 issue: 6 year: 2006 ident: 910_CR13 publication-title: J Am Geriatr Soc doi: 10.1111/j.1532-5415.2006.00745.x – volume: 57 start-page: 492 issue: 3 year: 2009 ident: 910_CR7 publication-title: J Am Geriatr Soc doi: 10.1111/j.1532-5415.2009.02137.x – volume: 381 start-page: 752 issue: 9868 year: 2013 ident: 910_CR9 publication-title: Lancet doi: 10.1016/S0140-6736(12)62167-9 – volume: 74 start-page: 32 year: 2018 ident: 910_CR24 publication-title: Arch Gerontol Geriatr doi: 10.1016/j.archger.2017.09.005 – volume: 14 start-page: 392 issue: 6 year: 2013 ident: 910_CR3 publication-title: J Am Med Dir Assoc doi: 10.1016/j.jamda.2013.03.022 – volume: 34 start-page: 25 issue: 1 year: 2018 ident: 910_CR2 publication-title: Clin Geriatr Med doi: 10.1016/j.cger.2017.09.004 – volume: 56 start-page: 898 issue: 5 year: 2008 ident: 910_CR4 publication-title: J Am Geriatr Soc doi: 10.1111/j.1532-5415.2008.01656.x – volume: 26 start-page: 288 issue: 2 year: 2015 ident: 910_CR12 publication-title: Ann Oncol Off J Eur Soc Med Oncol doi: 10.1093/annonc/mdu210 – volume: 56 start-page: 1932 issue: 10 year: 2008 ident: 910_CR16 publication-title: J Am Geriatr Soc doi: 10.1111/j.1532-5415.2008.01921.x – volume: 122 start-page: 2579 issue: 16 year: 2016 ident: 910_CR21 publication-title: Cancer doi: 10.1002/cncr.30046 – volume: 59 start-page: 1471 issue: 8 year: 2011 ident: 910_CR19 publication-title: J Am Geriatr Soc doi: 10.1111/j.1532-5415.2011.03493.x |
| SSID | ssj0017836 |
| Score | 2.3132637 |
| Snippet | Background
Identifying and assessing degree and type of frailty among older persons is a major challenge when targeting high risk populations to identify... Identifying and assessing degree and type of frailty among older persons is a major challenge when targeting high risk populations to identify preventive... Background Identifying and assessing degree and type of frailty among older persons is a major challenge when targeting high risk populations to identify... Abstract Background Identifying and assessing degree and type of frailty among older persons is a major challenge when targeting high risk populations to... |
| SourceID | doaj pubmedcentral hal proquest gale pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 21 |
| SubjectTerms | Activities of Daily Living Aged Aged, 80 and over Ambulatory care Data collection Death Evaluation Female Frail Elderly - statistics & numerical data Frailty French version Functional decline Functional Status Geriatric assessment Geriatric Assessment - methods Geriatrics Geriatry and gerontology Gerontology Health Sciences Health surveys Human health and pathology Humans Instruments (Equipment) Life Sciences Male Medicine Medicine & Public Health Methods Mortality Older people Primary care Proxy quality Quantitative psychology Questionnaires Rehabilitation reporting Research Article Risk Factors Santé publique et épidémiologie Setting (Literature) Statistical Theory and Methods Statistics for Life Sciences Surveys and Questionnaires Theory of Medicine/Bioethics Translations Translations and translating Validity Variables Vulnerability Vulnerable elders survey-13 Vulnerable Populations - statistics & numerical data |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9QwEB_0EPFF_LZ6ShXBL8KlaZukj6vscg_rIZwu9xY2acIeLF3ZL-7--5vpl9ZDffGpkKRpMplk5tckvwF4gy4oz50oGYJlxTLvJJvrkDB0NhJhM-tEHc5nNlUnJ_rsrPj6S6gvOhPW0AM3gjtKc4dGFN2OxNtMW6ERP3g0g0mmUudLS6svV0UHptr9A7qb0O5hJloebRKidWcElcg-souBFarJ-vsl-eaCTkRedzevn5r8beu0tkiTe3C3dSXjUdOF-3DDVw_g9pd2s_whTGfoYzchk-JViNHTiyd0t28R75ufZF3qbLck7mm79PGYgnZv4tPdeu8vUZTxu9n4FJ_vH8H3yfjb52PWBk9gKC-1ZT5XLmjpUlmGstSIMqyXOvA0WOuKuQuWW56H1AZ0CZ2al7mzQpaINmyBqEGlj-GgWlX-KcQi2CBCWjoEOxnxk8lCBO21K60oVEgj4J0wjWuZxSnAxdLUCENL08jfoPwNyd9cRPChf-VHQ6vxt8KfaIT6gsSIXSegnphWT8y_9CSCtzS-huYtNs7N2-sH2EViwDIjicBR8ELLCA4HJXG-uUH2a9SQQWOOR1NDaTxDuyME3ydYR6dApl0UNoaYhXAceJ5H8KrPpurpoFvlV7u6jOA5YmL8zpNG3_pPUaj7LFM8AjXQxEFbhjnV-aKmDFcUsy8pIvjY6ezPZv1R7s_-h9yfwx1RzzvBeH4IB9v1zr-AW26_Pd-sX9az9goyxD9Q priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZoQYgL70egoICQgCKrjpPYzgktaFc9LBVSYbU3a-3YbKXVpuxL5d8zkzipQkUvnFayvck4M2N_nx8zhLwFCMpyy0sKZFnSzFlBZ8onFMBGwk1mLK_T-UzG8uRETafFt7Dgtg7HKtsxsR6oy8riGvkRhmUBqMzy_NP5L4pZo3B3NaTQ2CM3MW022rmcdoQrwRsKYSczUeJonWBwd4qECWdJetGbi-qQ_d3AvDfHc5FXQefVs5N_baDW89Lo3v_26D65GxBpPGhM6AG54ZYPye2vYc_9ERlPAKo3mZfiyscAGOMRXhGcx7tmra0tnWwXGMLaLFw8xNzf6_h0u9q536CR-P1keAq_Hx6TH6Ph9y_HNORgoFakckNdLq1Xwqai9GWpQF7jhPIs9cbYYma9YYblPjUekKWVszK3hosSSIspgHzI9AnZX1ZL94zE3BvPfVpa4EwZhjkTBffKKVsaXkifRoS12tA2BCjHPBkLXRMVJXSjQA0K1KhAfRGRw-4v5010jusaf0YVdw0xsHZdUK1-6uCnOs2h38AZ88SZTBmugK46QF1JJlPrShORd2ggGt0fhLOzcIsBuoiBtPRAAP_krFAiIge9luC2tlf9BkysJ8zxYKyxjGUwfXHOdgk8ozUdHcaWtb60m4i87qrx8Xhebumqbd2GsxyoNbznaWOw3atSDrgskywismfKPVn6NcuzeR15XGLqv6SIyMfW6C_F-ud3f359J16QO7x2SU5ZfkD2N6ute0lu2d3mbL16VTv0HyRCTlY priority: 102 providerName: ProQuest |
| Title | Validation of the French version of the Vulnerable Elders Survey-13 (VES-13) |
| URI | https://link.springer.com/article/10.1186/s12874-020-0910-x https://www.ncbi.nlm.nih.gov/pubmed/32024470 https://www.proquest.com/docview/2357428055 https://www.proquest.com/docview/2352052496 https://hal.u-pec.fr/hal-04146220 https://pubmed.ncbi.nlm.nih.gov/PMC7003319 https://doaj.org/article/35c6395651eb48b28104e7411473cedb |
| Volume | 20 |
| WOSCitedRecordID | wos000513699400001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVADU databaseName: Open Access: BioMedCentral Open Access Titles customDbUrl: eissn: 1471-2288 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017836 issn: 1471-2288 databaseCode: RBZ dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAON databaseName: DOAJ (Directory of Open Access Journals) customDbUrl: eissn: 1471-2288 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017836 issn: 1471-2288 databaseCode: DOA dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1471-2288 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017836 issn: 1471-2288 databaseCode: M~E dateStart: 20010101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1471-2288 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017836 issn: 1471-2288 databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1471-2288 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017836 issn: 1471-2288 databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1471-2288 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017836 issn: 1471-2288 databaseCode: PIMPY dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLink Journals customDbUrl: eissn: 1471-2288 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017836 issn: 1471-2288 databaseCode: RSV dateStart: 20011201 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3rb9MwELfYhhBfeD8CowoICRiKcJzEdj52qNWQuqpaoSqfrNqx6aSqRX0J_nvunAcKAyT40qi2k9jnO9_9cvYdIS_BBKWZYUUEYFlEqTU8mkkXR2BsxEyn2jCfzmcyEMOhnE7zUXWOe1Pvdq9dkn6l9mIt-btNjKHZI4Q7qOMiMByPQNtJzNdwMZ40rgM8llC5L397W0sB-Tj9zWp8MMfNkFctzasbJn_xmnpl1L_9X8O4Q25VtmfYLZnlLrlml_fIjfPKu36fDCZglJc5lsKVC8E0DPt4GHAe7suvanXpZLfAYNV6YcMeZvnehOPdem-_A-3D15PeGK5vHpBP_d7H92dRlW0hMjwR28hmwjjJTcILVxQSYIm2XDqaOK1NPjNOU00zl2gHNqQRsyIzmvEC4InOAWaI5CE5XK6W9jEJmdOOuaQwgI5SDGjGc-aklabQLBcuCQitp0CZKhQ5ZsRYKA9JJFcllRRQSSGV1LeAnDS3fC3jcPyt8SnOa9MQQ2j7gtX6i6okUiUZjBvQYRZbnUrNJABTC_ZVnIrE2EIH5BVyhUJBh86ZWXVeAYaIIbNUlwPSZMCAPCDHrZYgoKZV_QL4qtWZs-5AYRlNQVExRvcxPKNmO1WtIhuFoYhgHmiWBeR5U42Px51xS7va-TaMZgCi4T2PSi5tXpUwsMBSQQMiWvzb6ku7Znk59zHGBSb5i_OAvK25-Ge3_kj3J__U-im5ybwYsIhmx-Rwu97ZZ-S62W8vN-sOORBT4X9lhxyd9oaji47_YAL_Rh_OR587Xux_AHNqSrY |
| linkProvider | Springer Nature |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1bb9MwFLa2gYAX7pfAgIBA4yJrjnOx84BQgVad1k1IG1XfTO3YdFLVjt7Y_hS_kXNym8LE3vbAUyTbcezk8_H3xfY5hLwCCspiwzMKYlnQyJqEDqULKJCNgOtIG56H8-n3xP6-HAzSr2vkd3UWBrdVVjYxN9TZ1OA_8m10ywJUmcXxx-OfFKNG4epqFUKjgMWuPf0Fkm3-YecLfN_XnHfah5-7tIwqQE0SigW1sTBOJiZMMpdlEurUNpGOhU5rkw6N00yz2IXaAVcyYpjFRvMkAxquU6DTIoR618kVsOMCxZ4Y1AIvwBMR5cppIJPteYDO5CkKNJyV6Ulj7stDBNQTwfoI92GeJ7nn92r-tWCbz4OdW__bG7xNbpaM228VQ-QOWbOTu-TaXrmn4B7p9UGKFJGl_KnzgRD7HTwCOfJXxb_EKrW_HKOLbj22fhtjm8_9g-VsZU8Bcf6bfvsArm_vk2-X0pcHZGMyndhHxOdOO-7CzIAmjNCNW5JyJ600mQasuNAjrPr6ypQO2DEOyFjlQkwmqgCMAsAoBIw68ci7-pbjwvvIRYU_IaTqgug4PE-Yzn6o0g6pMIZ-gyaOA6sjqbkEOW6BVQaRCI3NtEe2EJAKzRs0zgzLUxrQRXQUploJ6GvOUpl4ZLNREsySaWS_BEg3GtNt9RSmsQimZ87ZKoA6Kqiq0nbO1RlOPfKizsbqcT_gxE6XeRnOYh6l8JyHxQCpHxVy4J2RYB4RjaHTaEszZ3I0yj2rCwxtGKQeeV8NsrNm_fO9P764E8_J9e7hXk_1dvZ3n5AbPDcHnLJ4k2wsZkv7lFw1q8XRfPYsNyY--X7ZY-8PwM2ufw |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Zj9MwELZgQSteuI_AAgEhwYKidezEdh4LtFpEqVYqVPtm1Y5NV6rSVdNW8O-ZyYXCAhLiqZLtJD5m7Pk6428IeQEmKE0tyyMAyzJKnBXRXPk4AmMjZiYxllXpfGZjOZmo09PspMlzWrbR7q1Lsr7TgCxNxeboPPe1iitxVMZI0x4h9MHzLgIj8kqCcfQI16ezzo2AVxQaV-ZvH-sdRhVnf7czX15gYORFq_Ni8OQvHtTqYBrd-O8h3STXG5s0HNRCdItccsVtsv-p8brfIeMZGOt17qVw5UMwGcMRXhJchLv637a2dLZdIom1WbpwiNm_y3C6Xe_cd1iT8NVsOIXfw7vky2j4-d1x1GRhiKzgchO5VFqvhOUi93muAK4YJ5Sn3Btjs7n1hhqaem482JZWzvPUGiZygC0mA_gh-T2yV6wK94CEzBvPPM8toKYEic5ExrxyyuaGZdLzgNB2ObRtKMoxU8ZSV1BFCV3PkoZZ0jhL-ltAXnePnNf8HH9r_BbXuGuI1NpVwWr9VTeaqnkK4wbUmMbOJMowBYDVgd0VJ5Jbl5uAvEQJ0bgBQOfsvLnHAENEKi09EIBAGc2UCMhBryUoru1VPwcZ63XmeDDWWEYTOMAYo7sY3tGKoG52l1IjRRGsA03TgDzrqvH1GDFXuNW2asNoCuAavnO_ltjuU5yBZZZIGhDZk-VeX_o1xdmi4h6XmPwvzgLyppXon93647w__KfWT8n-yfuRHn-YfHxErrFKI1hE0wOyt1lv3WNy1e42Z-X6SaXrPwBqxlBu |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Validation+of+the+French+version+of+the+Vulnerable+Elders+Survey-13+%28VES-13%29&rft.jtitle=BMC+medical+research+methodology&rft.au=Belmin%2C+Jo%C3%ABl&rft.au=Khellaf%2C+Lyamna&rft.au=Pariel%2C+Sylvie&rft.au=Jarzebowski%2C+Witold&rft.date=2020-02-05&rft.pub=BioMed+Central&rft.eissn=1471-2288&rft.volume=20&rft_id=info:doi/10.1186%2Fs12874-020-0910-x&rft_id=info%3Apmid%2F32024470&rft.externalDocID=PMC7003319 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2288&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2288&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2288&client=summon |